Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2025-07-22 Regulatory Filings
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Strategic Data Partnership with GAP
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' (9260R) and is dated July 22, 2025. It announces a 'Strategic Partnership' and an agreement securing data rights, which is a material corporate event announcement. The text concludes with standard disclaimers regarding 'inside information' as stipulated under UK/EU Market Abuse Regulation and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure is characteristic of a regulatory news service announcement. Since the content is a specific corporate announcement (strategic partnership/data rights acquisition) and not a general regulatory filing fallback (RNS), nor is it a report itself (like 10-K or IR), it fits best under the general Regulatory Filings category (RNS) as the primary identifier for LSE news service releases, although it is a specific type of announcement. Given the options, RNS is the most appropriate code for a document explicitly sourced from the RNS news service detailing a material event.
2025-07-22 English
Trading Update
Earnings Release Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 3611R) on July 17, 2025. The content provides a 'trading update' anticipating revenues to be ahead of expectations for the financial year ending September 30, 2025, and mentions expected cash levels. This is a preliminary release of key financial performance indicators before the final results are announced in December 2025. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not a full report (10-K or IR), a transcript (CT), or a proxy statement (DEF 14A/PSI). FY 2025
2025-07-17 English
Share option awards and PDMR Dealing
Remuneration Information Classification · 1% confidence The document is identified by the RNS Number header and the closing statement referencing RNS, the news service of the London Stock Exchange. The content explicitly details 'Share Option Award & Director Bed & ISA Dealings' involving Persons Discharging Managerial Responsibilities (PDMRs) and includes structured tables providing transaction details (grant of options, sale/purchase of shares) as required by Market Abuse Regulation. This type of mandatory disclosure regarding insider transactions by directors/executives directly maps to the 'Director's Dealing' category.
2025-06-13 English
FDA Clearance of Alzheimer's Diagnostic Biomarker
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a specific operational milestone regarding the company's role in an FDA clearance for a client's diagnostic biomarker. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general corporate announcement regarding business operations and partnerships, it falls under the 'Regulatory Filings' (RNS) category.
2025-06-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the official regulatory template used in the UK for disclosing significant share ownership changes. The content explicitly details the issuer (IXICO PLC), the person subject to the notification (Maven Capital Partners UK LLP), and the percentage of voting rights held. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-05-20 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim results for six months ending 31 March 2025' and contains detailed financial highlights, operational highlights, a CEO statement, and financial performance data for the specified period. It is a comprehensive report of the company's financial status for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-05-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.